348
Views
21
CrossRef citations to date
0
Altmetric
Articles

Fruit extract of the medicinal plant Crataegus oxyacantha exerts genotoxic and mutagenic effects in cultured cells

, , , , &
Pages 161-170 | Received 08 Nov 2016, Accepted 12 Dec 2016, Published online: 17 Feb 2017

References

  • Alp, H., Soner, B. C., Baysal, T., and Şahin, A. S. 2015. Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats. Anat. J. Cardiol. 15: 970–975.
  • Ammon, H. P. and Händel, M. 1981. Crataegus, toxicology and pharmacology, Part I: Toxicity (author’s transl). Planta Med. 43: 105–120.
  • Azqueta, A., Meier, S., Priestley, C., Gutzkow, K. B., Brunborg, G., Sallete, J., Soussaline, F., and Collins, A. 2011. The influence of scoring method on variability in results obtained with the comet assay. Mutagenesis 26: 393–399.
  • Bahorun, T., Aumjaud, E., Ramphul, H., Rycha, M., Luximon-Ramma, A., Trotin, F., and Aruoma, O. I. 2003. Phenolic constituents and antioxidant capacities of Crataegus monogyna (Hawthorn) callus extracts. Nahrung 47: 191–198.
  • Belščakcvitanović, A., Durgo, K., Bušić, A., Franekić, J., and Komes, D. 2014. Phytochemical attributes of four conventionally extracted medicinal plants and cytotoxic evaluation of their extracts on human laryngeal carcinoma (HEp2) cells. J. Med. Food 17: 206–217.
  • Bernstein, L., Kaldor, J., McCann, J., and Pike, M. C. 1982. An empirical approach to the statistical analysis of mutagenesis data from the Salmonella test. Mutat. Res. 97: 267–281.
  • Blumenthal, M., Busse, W., and Goldberg, A. 1988. The complete German Commission E monographys, 142–144. Boston, MA: American Botanical Council.
  • Chang, W. T., Dao, J., and Shao, Z. H. 2005. Hawthorn: Potential roles in cardiovascular disease. Am. J. Chin. Med. 33: 1–10.
  • Choo, C. Y., Sulong, N. Y., Man, F., and Wong, T. W. 2012. Vitexin and isovitexin from the leaves of Ficus deltoidea with in vivo a-glucosidade inhibition. J. Ethnopharmacol. 142: 776–781.
  • Choy, W. N. 2001. Genetic toxicology and cancer risk assesment. New York: Marcel Dekker, Inc.
  • Claxton, L. D., Umbuzeiro, G. A., and DeMarini, D. 2010. The Salmonella mutagenicity assay: The stethoscope of genetic toxicology for the 21st Century. Environ. Health Persp. 118: 1515–1522.
  • Daniele, C., Mazzanti, G., Pittler, M. H., and Ernst, E. 2006. Adverse-event profile of Crataegus spp.: A systematic review. Drug Saf. 29: 523–535.
  • Fairbairn, D. W., Olive, P. L., and O’Neill, K. L. 1995. The comet assay: A comprehensive review. Mutat. Res. 339: 37–59.
  • Fenech, M. 2000. The in vitro micronucleus technique. Mutat. Res. 455: 81–95.
  • Fenech, M. 2006. Cytokinesis-block micronucleus assay evolves into a “cytome” assay of chromosomal instability, mitotic dysfunction and cell death. Mutat. Res. 600: 58–66.
  • Franco, E. S., Melo, E. S., Militão, G. C. G., Rocha, R. E. T., Silva, L. T. G. A., Jatobá, B. J. A., Silva, P. B. N., Santana, A. L. B. D., Silva, A. A. R., Silva, T. G., Nascimento, M. S., Maia, M. B. S. 2015. Evaluation of the acute toxicity, cytotoxicity, and genotoxicity of Chresta martii (Asteraceae). J. Toxicol. Environ. Health A 78: 1083–1093.
  • Hartmann, A. and Speit, G. 1997. The contribution of cytotoxicity to DNA-effects in the single cell gel test (comet assay). Toxicol. Lett. 90: 183–188.
  • Hosseinimehr, S. J., Mahmoudzadeh, A., Azadbakht, M., and Akhlaghpoor, S. 2009. Radioprotective effects of Hawthorn against genotoxicity induced by gamma irradiation in human blood lymphocytes. Radiat. Environ. Biophys. 48: 95–98.
  • Hosseinimehr, S. J., Azadbakht, M., Mousavi, S. M., Mahmoudzadeh, A., and Akhlaghpoor, S. 2007. Radioprotective effects of hawthorn fruit extract against gamma irradiation in mouse bone marrow cells. J. Radiat. Res. 48: 63–68.
  • Hosseinimehr, S. J., Azadbakht, M., Tanha, M., Mahmodzadeh, A., and Mohammadifar, S. 2011. Protective effect of hawthorn extract against genotoxicity induced by methyl methanesulfonate in human lymphocytes. Toxicol. Ind. Health 27: 363–369.
  • Jayalakshmi, R. and Niranjali-Devaraj, S. 2004. Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats. J. Pharm. Pharmacol. 56: 921–926.
  • Jhoo, J. W., Ang, C. Y., Heinze, T. M., Deck, J., Schnackenberg, L. K., Beger, R. D., Gragull, K., and Tang, C. S. 2007. Identification of C-glycoside flavonoids as potential mutagenic compounds in Kava. J. Food Sci. 72: C120–C125.
  • Maron, D. M. and Ames, B. N. 1983. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113: 173–215.
  • Mohammed, R. S., Abou-Zeid, A. H., El-Hawary, S., Sleem, A. A., Ashour, W. E. 2014. Flavonoid constituents, cytotoxic and antioxidant activities of Gleditsia triacanthos L. leaves. Saudi J. Biol. Sci. 21: 547–553.
  • Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55–63.
  • Nascimento, D. F. 2009. Estudo de toxicologia clínica de um fitoterápico contendo Passiflora incarnata L., Crataegus oxyacantha L. e Salix alba L. em voluntários saudáveis. Braz. J. Pharmacog. 261.
  • OECD, 487. 2014. In vitro mammalian cell micronucleus test. OECD guideline for the testing of chemicals. Paris, France.
  • OECD, 489. 2014. In vivo mammalian alkaline comet assay. OECD Guideline for the testing of Chemicals. Paris, France.
  • Rigelsky, J. M. and Sweet, B. V. 2002. Hawthorn: pharmacology and therapeutic uses. Am. J. Health Syst. Pharm. 59: 417–422.
  • Riss, T. L. 2013. Cell viability assays. Bethesda: Assay guidance manual.
  • Strober, W. 2001. Trypan blue exclusion test on cell viability. Curr. Protoc. Immunol. doi:10.1002/0471142735.ima03bs21.
  • Snijman, P. W., Swanevelder, S., Joubert, E., Green, I. R., Gelderblom, W. C. A. 2007. The antimutagenic activity of the major flavonoids of rooibos (Aspalathus linearis): Some dose-response effects on mutagen activation-flavonoid interactions. Mutat. Res. 631: 111–123.
  • Tabach, R., Rodrigues, E., and Carlini, E. A. 2009. Preclinical toxicological assessment of a phytotherapeutic product-CPV (based on dry extracts of Crataegus oxyacantha L., Passiflora incarnata L., and Valeriana officinalis L.). Phytother. Res. 23: 33–40.
  • Tice, R. R., Agurell, E., Anderson, D., Burlinson, B., Hartmann, A., Kobayashi, H., Miyamae, Y., Rojas, E., Ryu, J. C., and Sasaki, Y. F. 2000. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 35: 206–221.
  • Trindade, C., Bortolini, G. V., Costa, B. S., Anghinoni, J. C., Guecheva, T. N., Arias, X., Césio, M. V., Heinzen, H., Moura, D. J., Saffi, J., Salvador, M., and Henriques, J. A. P. 2016. Antimutagenic and antioxidant properties of the aqueous extracts of organic and conventional grapevine Vitis labrusca cv. Isabella leaves in V79 cells. J. Toxicol. Environ. Health A 79: 825–836.
  • Wang, J., Xiong, X., and Feng, B. 2013. Effect of Crataegus usage in cardiovascular disease prevention: an evidence-based approach. Evid. Based Complement. Alternat. Med. 2013: 149363.
  • Weihmayr, T. and Ernst, E. 1996. Therapeutic effectiveness of Crataegus. Fortschr. Med. 114: 27–29.
  • Wenjuan-Wei, W., Ying, X., Zhang, W., Chen, Y., Leng, A., and Jiang, C. 2014. Effects of vitexin-2”-O-rhamnoside and vitexin-4”-O-glucoside on growth and oxidative stress-induced cell apoptosis of human adipose-derived stem cells. J. Pharm. Pharmacol. 66: 988–997.
  • Zhang, Z., Chang, Q., Zhu, M., Huang, Y., Ho, W. K., and Chen, Z. 2001. Characterization of antioxidants present in hawthorn fruits. J. Nutr. Biochem. 12: 144–152.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.